JAKARTA - The US Food and Drug Administration (FDA) released a Safety Communication regarding the dangers of using smartwatches and smart rings with blood glucose gauge claims.

According to the FDA, the two devices that do not puncture the skin are different from smartwatch applications that display data from official blood glucose measuring devices. The FDA also has not allowed devices without official measuring devices.

"The FDA has not approved any smartwatch or smart ring intended to measure or estimate the value of blood glucose itself," the FDA said through its official website on Wednesday, February 21.

For the FDA, the use of smartwatches and smart rings with false claims can endanger diabetics. With inaccurate results, diabetics may be wrong in using doses of blood glucose reduction drugs.

"Consumptioning too many of these drugs can rapidly lead to harmful low levels of glucose, causing mental confusion, coma, or death within hours of the error," the FDA said.

Therefore, the FDA emphasizes to the US public not to buy and use smartwatches or smart circuits with claims to measure blood glucose levels. This device is sold freely and the public must know its effectiveness.

This device may be sold through the online market or directly from the seller. Please note that the safety and effectiveness of this device has not been reviewed by the FDA and the use of this device can result in in inaccurate blood glucose levels measurements," the FDA said.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)

Add VOI as a Preferred Source
Follow VOI news updates across Google.
+